Yemaachi Biotech
Cancer innovation shaped by Africa — for the world
Yemaachi Biotech is an African-rooted biotechnology company building the world's most diverse cancer bio-database through clinical genomic research across Africa. Their goal is to develop next-generation cancer drugs that are effective across diverse populations, advancing inclusive precision oncology. The company is supported by a global network of partners from the public, private, and non-profit sectors.
Yemaachi conducts clinical genomic research across multiple cancer types in Africa to build a robust cancer knowledge base used to develop more inclusive cancer therapies.
oncology researchers, pharmaceutical companies, and healthcare institutions focused on diverse populations
Background.
- Status
- launched
- Business model
- unknown
- Company
- Yemaachi Biotech
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.